Abstract:Objective To investigate the clinical features, steroid response, and recurrence of IgG4 -associated sclerosing cholangitis (IgG4 -SC), and to shorten the time for clinical diagnosis and reduce recurrence rate .Methods A total of 12 patients with IgG4 -SC who were admitted to Peking University First Hospital from December 2011 to March 2017 were enrolled, and they all met the clinical diagnostic criteria for IgG4 -SC in 2012.A retrospective analysis was performed for their clinical data , clinical features, and follow -up data.Results Of all 12 patients, the male/female ratio was 11:1.The mean age of onset was 61.7 ±8.6 years, and the mean time to a confirmed diagnosis was 24.2 months.Of all 12 patients,11 (92%) had jaundice, with a mean serum total bilirubin level of 198.7 ±57.7 μmol/L.There were varying degrees of increase in serum alanine aminotransferase level (range 55 -453 U/L).Of all patients, 5 (41.7%) had acute abdominal pain, with a mean CA19 -9 level of 60.8 ±12.5 U/ml.Serum IgG4 was increased by 1.5 -18.9 times, with a mean level of 7.7 ±2.0 g/L.Magnetic resonance cholangiopancreatography (MRCP) performed for all patients showed typical manifestations including bile duct wall thickening, lumen stenosis, and intrahepatic and extrahepatic bile duct dilatation ; 11 patients (92%) were found to have autoimmune pancreatitis,and 2 (16.7%) had involvement of more than 3 visceral organs.In two patients who underwent biliary stent implantation before treatment, the biliary stent was removed after 4 -6 weeks of steroid treatment.The mean duration of steroid response was 5.4 months.Among the 8 patients who underwent steroid treatment , 4 (50%,4/8) experienced recurrence during the reduction of the dose of steroid , among whom 2 experienced recurrence within 8 -12 weeks after drug withdrawal.Conclusion IgG4 -SC needs a long time for prognosis,with frequent misdiagnosis and missed diagnosis .Serum IgG4 level should be measured for elderly male patients with an acute onset of jaun - dice and bile duct stenosis, bile duct wall thickening, and involvement of the pancreas on MRCP.Steroid treatment should be given as early as possible after diagnosis.Patients may need at least 5 -6 months to achieve steroid response.The dose of steroid should be reduced slowly and recurrence and tumorigenesis should be closely monitored .

Clinical diagnostic criteria for IgG4‐related sclerosing cholangitis 2020

Differentiating immunoglobulin g4-related sclerosing cholangitis from hilar cholangiocarcinoma

Current approach to the diagnosis of IgG4-related disease – Combination of comprehensive diagnostic and organ-specific criteria

IgG4-related Autoimmune Pancreatitis,Hepatopathy and Sclerosing Cholangitis:Advances in Pathogenesis, Diagnosis and Treatment

Clinical features of IgG4-associated sclerosing cholangitis:An analysis of 12 cases

Comparative clinical characteristics and natural history of three variants of sclerosing cholangitis: IgG4-related SC, PSC/AIH and PSC alone.

Endoscopic Retrograde Cholangiopancreatography-Related Procedures for the Differential Diagnosis of Isolated Immunoglobin G4-Related Sclerosing Cholangitis and Perihilar Cholangiocarcinoma

Validation of the Diagnostic Criteria for IgG4-Related Periaortitis/Periarteritis and Retroperitoneal Fibrosis (IgG4PA/RPF) 2018, and Proposal of a Revised 2023 Version for IgG4-Related Cardiovascular/Retroperitoneal Disease

A Review of IgG4-related Sclerosing Cholangitis (IgG4-SC)

A Case Report of Immunoglobulin G4-related Sclerosing Cholangitis with Multiple Relapse

Immunoglobulin (Ig) G4-related sclerosing cholangitis in patients resected for presumed perihilar cholangiocarcinoma: a 10-year experience

Sclerosing Cholangitis Related to IgG4: Not Always a Curable Entity

Advances in diagnosis and treatment of IgG4-related hepatobiliary and pancreatic diseases

Unexpected diagnosis: IgG4-related sclerosing cholangitis with normal serum IgG4 levels - Unraveling diagnostic and therapeutic challenges

Diagnosis and Differential Diagnosis of Immunoglobulin G4-related Hepatobiliary Disease

Clinical and Pathological Characteristics of IgG4-Related Periaortitis/Periarteritis and Retroperitoneal Fibrosis Diagnosed Based on Experts’ Diagnosis

The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease

The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience

IgG4-related cholangiopathy, pancreatopathy and lymphadenopathy

IgG4-related sclerosing cholangitis associated with essential thrombocythemia: A case report

IgG4 Sclerosing Cholangitis and Post Infantile Giant Cell Hepatitis: A Case Report of an Extraordinary Co-presentation